Angewandte Chemie International Edition · 2021 · 58 citations · 18 references
PharmacyOncologyPharmacologyBiomaterialsDrug DeliveryNanoparticle Drug DeliveryCancer NanomedicineDrug Delivery EngineeringNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignAnticancer Drug LoadingHydrophobic Drug LoadingNanocarrier-based ProdrugsNanocarriersOff-target Tissue EffectsProtein-based NanocarriersSupramolecular InteractionsTumor-targeted Prodrugs
Supramolecular nanodrug assembly driven by supramolecular chemistry is becoming a powerful strategy for medication. The potential of engineered proteins as building blocks for nanoformulations is rarely investigated. Here, we developed a new generation of recombinant protein-based nanodrug carriers, which is very efficient for loading and delivering the hydrophobic prodrug aldoxorubicin. Significantly enhanced anti-tumor effects in osteosarcoma (OS) models were observed. The half-life of the nanodrug reached almost two days and the corresponding bioavailability increased by 17-fold. This is significantly superior to other drug counterparts, empowering long-acting OS treatment scenarios. Importantly, off-target side effects of the prodrug, including cardiotoxicity and lung-metastasis, were greatly mitigated with our medication. Thus, our assembly strategy enables the customized design of advanced nanodelivery systems employing broader biomaterial building blocks for cancer therapy.
18
Roy van der Meel, Einar Sulheim, Yang Shi et al. · Nature Nanotechnology · 2019 · 1.2K citations · Full text
Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors
Huiping Sun, Jinghan Su, Qingshuo Meng et al. · Advanced Materials · 2016 · 647 citations
Immuno-genomic landscape of osteosarcoma
Chia-Chin Wu, Hannah C. Beird, J. Andrew Livingston et al. · Nature Communications · 2020 · 244 citations · Full text
Medicine, Immunology, Oncology +17